Reducing Your Risk
These simple steps can go far toward keeping you — and your family — relatively safe from melanoma:
Limit sun exposure. Stay indoors between 10 a.m. and 2 p.m., when the sun is strongest.
Don’t let your children get sunburned. “The earlier in life sunburn happens, the greater the risk for melanoma later on,” Dr. Childs said.
Wear sunscreen with a sun protection factor (SPF) of 30 or higher when in the sun. Apply it thoroughly across exposed areas and keep reapplying sunscreen at no more than two-hour intervals during sustained exposure to the sun (for example, while on the beach, on the farm or at a job site). “You can’t apply sunscreen just once and then stay out in the sun for 10 hours and not expect to have a sunburn,” Dr. Childs said.
Wear protective clothing. Stylish summer clothes that block UV rays are widely available online and in chain sporting goods stores. Also, wear light colors, which reflect sunlight away from your body.
Avoid tanning salons. Just one indoor tanning session can increase your risk of melanoma by 20%, according to the American Academy of Dermatology (AAD). A single “tan in a can” also can raise your risk of two other skin cancers: squamous cell carcinoma and basal cell carcinoma, the AAD reports.
Advances in Treating Melanoma
Immunotherapies that enable the immune system to find and eliminate cancer cells, and targeted therapies that act on specific genetic proteins that cause abnormal cell growth, have drastically changed the prognosis for melanoma. Additionally, the continued development of experimental medications that lead to even more hope.
“Just 10 to 15 years ago, if we had a new patient with stage 4 melanoma, you couldn’t be very hopeful, nor could you offer many treatment options. The situation is far different today,” Dr. Wallace said.
“The immunotherapies we are able to employ now often drive the immune system to take over and counteract the disease, even after it’s become metastatic,” Dr. Childs said.
RCCA network medical oncologists are experts at evaluating and treating later-stage melanomas. The physicians regularly participate in clinical trials of treatments that target melanoma and other solid tumors and blood-based cancers. Patients typically are referred to an RCCA cancer specialist after their melanoma has been diagnosed, initially treated and staged by a dermatologist and dermatologic surgeon.
“We treat patients according to the best current evidence using the latest treatments,” Dr. Wallace said. “It’s a matter of knowing what treatment strategy is right for each patient and making sure they can take advantage of the best existing therapies.”
Dr. Childs and Dr. Wallace are among more than 80 oncology physicians and nurse clinicians practicing at 20-plus RCCA care centers throughout New Jersey, Connecticut, Massachusetts and the Washington, D.C., area. RCCA provides care to roughly 22,000 new cancer patients and 225,000 established patients each year, offering those patients immunotherapy, targeted treatment, cell-based therapy and other cutting-edge treatments and diagnostic modalities, as well as access to clinical trials. RCCA care centers also provide infusion services for patients with non-oncology conditions — such as multiple sclerosis, rheumatoid arthritis, Crohn’s disease and others — who are being treated with intravenously-administered medications.